Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate Read more
Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema Read more
DCGI instructs industry to follow defined pathways for application submission of rational FDCs Read more
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension Read more